The observed lower glucose utilization in patients with AD as well as animal models of AD has been associated with a decreased content of GLUT1 and GLUT3 in the cortex and hippocampus which are major structures associated with cognition and memory [15,16,17,18]. Here, SLC2A1 is linked to Alzheimer disease.